Safety, efficacy and pitfalls of fibrocyte application in the treatment of diabetic foot ulcer

International Wound Journal

Volumn 12, Issue 1, 2015, Pages 27-31

  Behjati, Mohaddeseh ^a   Hashemi, Mohammad ^b   Shoarayenejati, Alireza ^c   Karbalaie, Khadijeh ^c   Nasr Esfahani, Mohammad H ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Isfahan University of Medical Siences   (Iran)

^c ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

Author keywords

Diabetic foot ulcer; Fibrocyte; Wound healing

Indexed keywords

COLLAGEN TYPE 1; MEMBRANE COFACTOR PROTEIN;

ADHERENT CELL; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CENTRIFUGATION; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC PATIENT; FEMALE; FIBROCYTE TRANSPLANTATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WOUND CARE; CELL SEPARATION; CELL TRANSPLANTATION; MONONUCLEAR CELL; PATIENT ATTITUDE; PROCEDURES; TRANSPLANTATION;

CELL SEPARATION; CELL TRANSPLANTATION; DIABETIC FOOT; HUMANS; LEUKOCYTES, MONONUCLEAR; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 84921436304     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/iwj.12043     Document Type: Article

References (31)

1. Yang L, Scott PG, Giuffre J, Shankowsky HA, Ghahary A, Tredget EE. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002;82:1183-92.
2. Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005;304:81-90.
3. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994;1:71-81.
4. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007;87:858-70.
5. Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 2008;83:1323-33.
6. Fathke C, Wilson L, Hutter J, Kapoor V, Smith A, Hocking A, Isik F. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells 2004;22:812-22.
7. Chesney J, Bacher M, Bender A, Bucala R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 1997;94:6307-12.
8. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166:7556-62.
9. Clark RA. Fibrinogen and wound healing. Ann N Y Acad Sci 2001;936:355-67.
10. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-6.
11. Akbar NA, Salmon M. Chronic inflammatory states maintained by abnormal stromal microenvironments. Immunology 1996;89:51.
12. Mattoli S, Bellini A, Schmidt M. The role of a human hematopoietic mesenchymal progenitor in wound healing and fibrotic diseases and implications for therapy. Curr Stem Cell Res Ther 2009;4:266-80.
13. Lama VN, Phan SH. The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond. Proc Am Thorac Soc 2006;3:373-6.
14. Abu El-Asrar AM, Struyf S, Van Damme J, Geboes K. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol 2008;92:699-704.
15. Wang JF, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen 2007;15:113-21.
16. Shaw T, Martin P. Epigenetic reprogramming during wound healing: loss of polycomb-mediated silencing may enable upregulation of repair genes. EMBO Rep 2009;10:881-6.
17. Clark RAF. Wound repair: overview and general considerations. In: Clark RAF, Henson PM, editors. The molecular and cellular biology of wound repair. New York: Plenum, 1996:3-35.
18. Jaul E. Non-healing wounds: the geriatric approach. Arch Gerontol Geriatr 2008;49:224-6.
19. McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, Pecoraro RF. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 1995;18:216-9.
20. Rose G, Duerksen F, Trepman E, Cheang M, Simonsen JN, Koulack J, Fong H, Nicolle LE, Embil JM. Multidisciplinary treatment of diabetic foot ulcers in Canadian aboriginal and non-aboriginal people. Foot Ankle Surg 2008;14:74-81.
21. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. Diabetes Care 2002;25:1835-9.
22. Chen B, Murphy G, Orgill D, Guo L. Fibrocytes, the fibroblast progenitor cells of hematopoietic lineage, enhance cutaneous wound healing in diabetic mice. AAPS 89th Annual Meeting Abstract.
23. Han S-K, Choi K-J, Kim W-K. Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study. Plast Reconstr Surg 2004;114:1783-9.
24. Wu J, Xue X, Liu J, Si X, Yang G. Effect of insulin on burn wound healing in aging diabetes mellitus rats. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2009;23:1482-6.
25. Toker S, Gulcan E, Cayc MK, Olgun EG, Erbilen E, Ozay Y. Topical atorvastatin in the treatment of diabetic wounds. Am J Med Sci 2009;338:201-4.
26. Curnow SJ, Fairclough M, Schmutz C, Kissane S, Denniston AKO, Nash K, Buckley CD, Lord JM, Salmon M. Distinct Types of Fibrocyte Can Differentiate from Mononuclear Cells in the Presence and Absence of Serum. PLoS One 2010;5:e9730.
27. Wagner FW Jr. The diabetic foot. Orthopedics 1987;10:163-72.
28. Pilling D, Buckley CD, Salmon M, Gomer RH. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 2003;171:5537-46.
29. Stirieter RM, Keeley EC, Burdick MD, Mehrad B. The role of circulating mesenchymal projenitor cells, fibrocytes, in promoting pulmonary fibrosis. Trans Am Clin Climatol Assoc 2009;120:49-59.
30. Blakytny R, Jude EB. Altered molecular mechanisms of diabetic foot ulcers. Int J Low Extrem Wounds 2009;8:95-104
31. Trousdale RK, Jacobs S, Simhaee DA, Wu JK, Lustbader JW. Wound closure and metabolic parameter variability in a db/db mouse model for diabetic ulcers. J Surg Res 2009;151:100-7.